Product Code: ETC6181614 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The generic drug market in Australia plays a crucial role in ensuring affordable access to essential medicines. Driven by the need to reduce healthcare costs, the market has experienced consistent growth. Government policies such as the Pharmaceutical Benefits Scheme (PBS) have promoted the use of generics by offering reimbursement incentives. Local manufacturers and international players both compete in this space, with a strong focus on producing bioequivalent alternatives to branded drugs. Increased prevalence of chronic diseases and rising awareness among consumers about cost-effective alternatives further support market expansion.
The generic drug market in Australia is witnessing steady growth, driven by an increasing focus on cost-effective alternatives to branded drugs. The governments Pharmaceutical Benefits Scheme (PBS) continues to play a pivotal role in encouraging the use of generics through incentives and regulatory support. The expiration of patents on blockbuster drugs is opening new opportunities for generic manufacturers. Furthermore, the rising incidence of chronic diseases and the aging population are increasing demand for affordable medication, positioning generics as an essential component of healthcare delivery.
The Australian generic drug market faces challenges in pricing pressures, as government policies like the Pharmaceutical Benefits Scheme (PBS) drive prices downward. Additionally, competition from biosimilars and complex regulatory approval processes for new generics make it harder for manufacturers to maintain profitability and market share.
Australia`s generic drug market provides steady investment opportunities due to rising healthcare costs and the government`s push for affordable medicines. Investment prospects exist in manufacturing, distribution, and retail of off-patent drugs. Companies that can comply with Australias stringent regulatory framework and maintain cost-efficiency stand to benefit. There`s also potential for expanding generic drug portfolios to treat chronic conditions such as diabetes, cardiovascular diseases, and mental health disorders, which are prevalent in the country.
The Pharmaceutical Benefits Scheme (PBS) and the Therapeutic Goods Administration (TGA) guidelines dominate the regulatory environment for generic drugs in Australia. Government initiatives aim to encourage generic drug uptake to reduce healthcare costs, while strict quality and bioequivalence requirements ensure public safety.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Generic Drug Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Generic Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Generic Drug Market - Industry Life Cycle |
3.4 Australia Generic Drug Market - Porter's Five Forces |
3.5 Australia Generic Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Generic Drug Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.7 Australia Generic Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Australia Generic Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Generic Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Australia Generic Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Generic Drug Market Trends |
6 Australia Generic Drug Market, By Types |
6.1 Australia Generic Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Generic Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Generic Drug Market Revenues & Volume, By Simple Generics, 2021- 2031F |
6.1.4 Australia Generic Drug Market Revenues & Volume, By Super Generics, 2021- 2031F |
6.2 Australia Generic Drug Market, By Brand |
6.2.1 Overview and Analysis |
6.2.2 Australia Generic Drug Market Revenues & Volume, By Pure Generic, 2021- 2031F |
6.2.3 Australia Generic Drug Market Revenues & Volume, By Branded Generic, 2021- 2031F |
6.3 Australia Generic Drug Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Australia Generic Drug Market Revenues & Volume, By Central Nervous System (CNS), 2021- 2031F |
6.3.3 Australia Generic Drug Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.4 Australia Generic Drug Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.3.5 Australia Generic Drug Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 Australia Generic Drug Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.7 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Generic Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Generic Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Generic Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 Australia Generic Drug Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.5 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Generic Drug Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Generic Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Generic Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Australia Generic Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Australia Generic Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Generic Drug Market Import-Export Trade Statistics |
7.1 Australia Generic Drug Market Export to Major Countries |
7.2 Australia Generic Drug Market Imports from Major Countries |
8 Australia Generic Drug Market Key Performance Indicators |
9 Australia Generic Drug Market - Opportunity Assessment |
9.1 Australia Generic Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Generic Drug Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.3 Australia Generic Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Australia Generic Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Generic Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Australia Generic Drug Market - Competitive Landscape |
10.1 Australia Generic Drug Market Revenue Share, By Companies, 2024 |
10.2 Australia Generic Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |